Skip to main content
. 2022 Jan 6;139(1):104–117. doi: 10.1182/blood.2020010342

Figure 3.

Figure 3.

Reduced tyrosine phosphorylation in resting and activated mouse platelets harboring deletion of Vlk compared with control. (A) Immunoblots of lysates (Lys.) and supernatants (Sup.) from Vlkf/f (CTL) and Vlk-cKO (cKO) platelets resting or stimulated with 5 U/mL thrombin for 15 minutes. Anti-Tsp1 and anti-PF4 antibodies were used as markers of platelet activation, and anti-GAPDH antibody was used to examine total protein levels in lysates. (B) Lysates from panel A were used to examine tyrosine phosphoproteins by immunoblot (IB) of p-Tyr–enriched fraction (IP). Black arrows indicate phosphobands decreased in Vlk-cKO (cKO) compared with Vlkf/f (CTL) in resting (a-f) and activated (1-10) platelets. Cumulative percent tyrosine phosphorylation in phosphorylated proteins indicated in representative figure in panel B from resting (C) and activated (D) control and Vlk-cKO lysates. Data are expressed as mean ± standard deviation (SD); n = 3 independent experiments. Quantifications were normalized to GAPDH protein expression. (E) Representative image of input and p-Tyr IP fraction from resting and thrombin-stimulated supernatants analyzed by using SDS-polyacrylamide gel electrophoresis (PAGE) with 8% gels and immunoblotting with anti–p-Tyr and anti-Tsp1 antibodies. Phenyl phosphate (PP) was used as negative control for nonspecific binding to p-Tyr beads. Black arrows indicate bands decreasing in cKO compared with CTL. (F) Cumulative percent phosphorylation of Tsp1 in activated supernatants from Vlk-cKO compared with CTL; n = 3 independent experiments.